Pinpoint TherapeuticsAbout

About company

Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy, a key cell survival and treatment resistance pathway in cancer. Pinpoint inhibitors target a recently discovered enzyme in the autophagy pathway called PPT1, which is highly expressed across most cancers. These inhibitors could be applied to a broad range of cancers alone or in combination to overcome therapy resistance.

• NL
• pciinfo@pci.upenn.edu
• Unknown
• www.ctt.upenn.edu/upstart/pinpoint-therapeutics/
• Not verified company